<SEC-DOCUMENT>0001640334-23-000534-index.html : 20230331 <SEC-HEADER>0001640334-23-000534.hdr.sgml : 20230331 <ACCEPTANCE-DATETIME>20230331161606 ACCESSION NUMBER: 0001640334-23-000534 CONFORMED SUBMISSION TYPE: NT 20-F PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230331 DATE AS OF CHANGE: 20230331 EFFECTIVENESS DATE: 20230331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NYMOX PHARMACEUTICAL CORP CENTRAL INDEX KEY: 0001018735 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: NT 20-F SEC ACT: 1934 Act SEC FILE NUMBER: 001-12033 FILM NUMBER: 23787886 BUSINESS ADDRESS: STREET 1: 9900 CAVENDISH BLVD., SUITE 306 STREET 2: ST. LAURENT CITY: QUEBEC CANADA STATE: A8 ZIP: H4M 2V2 BUSINESS PHONE: 1-800-936-9669 MAIL ADDRESS: STREET 1: 9900 CAVENDISH BLVD., SUITE 306 STREET 2: ST. LAURENT CITY: QUEBEC CANADA STATE: A8 ZIP: H4M 2V2 </SEC-HEADER> <DOCUMENT> <TYPE>NT 20-F <SEQUENCE>1 <FILENAME>nymox_nt20f.htm <DESCRIPTION>NT 20-F <TEXT> Document 1 - file: nymox_nt20f.htm
</DOCUMENT> </SEC-DOCUMENT>